Abcam

E422482

Abcam is a biotechnology company specializing in the production and distribution of research-grade antibodies and related reagents for life science research.

All labels observed (1)

Label Occurrences
Abcam canonical 1

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf biotechnology company
public company
acquiredBy Danaher Corporation NERFINISHED
acquisitionAnnounced 2023
coreProduct ELISA kits
cellular imaging reagents
immunoassay reagents
protein reagents
recombinant antibodies
research-grade antibodies
countryOfOrigin United Kingdom
focusArea antibody production
antibody validation
cell biology research
epigenetics research
immunology research
neuroscience research
proteomics research
foundedBy David Cleevely NERFINISHED
Jonathan Milner NERFINISHED
Tony Kouzarides NERFINISHED
hasBusinessModel e-commerce distribution of reagents
hasOfficeLocation Amsterdam, Netherlands NERFINISHED
Berlin, Germany NERFINISHED
Cambridge, Massachusetts, United States NERFINISHED
Hong Kong NERFINISHED
Melbourne, Australia NERFINISHED
Paris, France NERFINISHED
Shanghai, China NERFINISHED
Singapore NERFINISHED
Tokyo, Japan NERFINISHED
Toronto, Canada NERFINISHED
hasResearchTool Knockout-validated antibodies
Recombinant monoclonal antibodies
hasSubsidiary Abcam Inc. NERFINISHED
headquartersLocation Cambridge, United Kingdom NERFINISHED
inception 1998
industry biotechnology
life sciences
research reagents
listedOn AIM NERFINISHED
offersService bulk and OEM supply of reagents
custom antibody production
technical support for antibody use
servesIndustry academic research
biotechnology industry
pharmaceutical industry
tickerSymbol ABC NERFINISHED
website https://www.abcam.com

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.